Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail
-

Public Calendar: June 14-18, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 14-18, 2010
FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 6/14/10 Washington, DC Murray Lumpkin, Kanya Balakrishna, Sandra Kweder N/A Speech at Drug Information Association Meeting
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 6/15/10 Seattle, WA N/A N/A Speech at the William H. Sorrell Lecture Series on Tobacco Policy and Enforcement
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 6/17/10 New York, NY N/A N/A Speech at the Primary Care Development Corporation
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 6/14/10 Cambridge, MA  N/A Rich Aldrich (Longwood Founders Fund); Josh Boger,  Matt Emmens (Vertex); Mike Bonney (Cubist Pharmaceuticals); Jessica Chutter (Morgan Stanley); Michelle Dipp; Mark Levin (Third Rock); John Maraganore (Alnylam); Alex Margolin (Alnara); Richard Pops (Alkermes); Henri Termeer (Genzyme);  Christoph Westphal, Sylvia Westphal, Andrew Witty (GlaxoSmithKline) Development of Medical Products that Meet Public Health Needs
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 6/15/10 Boston, MA N/A Attendees at the Conference Speech at Boston Biotech CEO Conference
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 6/15/10 Boston, MA N/A Barry Zuckerman Pediatrics 
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 6/15/10 Washington, DC  N/A Attendees at the Conference Speech at Summit on Breastfeeding
Russell Abbott, Deputy Commissioner for Administration 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine 6/15/10 Teleconference Laura Alvey, Cathy Beck, Diane Heinz, Jeffrey Punderson, William Flynn John Clifford, Bethany Jones, Sharon Fisher, Jill Roland (Animal and Plant Health Inspection Service, U.S. Department of Agriculture) Outreach Initiatives
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health 6/18/10 Washington, DC N/A Leadership from NIH, FDA, CMS, AHRQ, NCI, The White House, Senior House and Senate staff, as well as collegues advocacy and the private sector CER Forum Panel Discussion - Comparative Effectiveness
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs 6/14/10 Washington, DC N/A N/A Speech: DIA Annual Meeting - International Cooperation Among Regulators, Including the Exchange of Confidential Information
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs 6/16/10 Washington, DC N/A N/A Speech: DIA Annual Meeting - Acceptability of Foreign Clinical Data for Registration of New Medicines
Beth Martino, Associate Commissioner for External Affairs 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research 6/15/10-
6/17/10		 Geneva, Switzerland N/A N/A Regulation of vaccines, therapeutics and blood products
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health 6/18/10 Silver Spring, MD Jonathan Sackner-Bernstein, Alberto Gutierrez, Catherine Norcio, Janine Morris, Mary Long, Michel Janda, Carolyn Neuland, Herbert Lerner, Pamela Scott Brian Fennerty, Pat Blake, Greg Ginsber  (American Society for Gastroinetestinal Endoscopy [ASGE]) Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research 6/15/10 Toronto, Canada N/A N/A First International Workshop on Anesthesia and Alzheimers Disease
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods 6/18/10 Silver Spring, MD Sharon Natanblut Ladd Wiley, Wayne Pines (Alliance for a Stronger FDA); Abby Blunt (Kraft); David Plunkett (Center for Science in the Public Interest); Scott Faber (Grocery Manufacturers Association); Daniel Felton (International Bottled Water Association); Lee Sanders (American Bakers Association); Robert Garfield (American Frozen Food Institute) Meet and Greet with the Alliance for a Stronger FDA
Ralph Tyler, J.D., Chief Counsel 6/17/10 Silver Spring, MD  Elizabeth Dickinson, Wendy Vicente, Lynn Whipkey-Mehler, Kim Dettelbach, Eric Blumberg, Dan Sigelman Peggy Dotzel, William Schultz (Zuckerman Spaeder); Richard Dean (Tucker, Ellis & West) Generic Labeling Preemption
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs 6/14/10-
6/18/10		 N/A N/A N/A No Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research 6/15/10 Washington, DC N/A Paul Eisenberg (Amgen, Inc.); Ellen Sigal (Friends of Cancer Research); Robert Giffin (Center for Medical Technology Policy) Implications of Health Care Reform for Product Safety and the Pharmaceutical Industry
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research 6/16/10 Washington, DC John Jenkins James McLeod (Merck Research Laboratories); Peter Honig (Peter Honig Regulatory and Medical Advisors, LLC); Robert Meyer (Merck & Co., Inc.); Gerald Migliaccio (Pfizer Inc.) Quality-by-design:  Linking Quality to Safety and Efficacy- Parts 1 & 2
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research 6/17/10 Washington, DC Deborah Autor, ShaAvhree Buckman, Robert Temple, Gerald Dal Pan, John Jenkins, Sandra Kweder, Justina Molzon N/A CDER Town Hall- Parts 1 & 2
-
-